4.6 Article

Imaging Essential Tremor

期刊

MOVEMENT DISORDERS
卷 25, 期 6, 页码 679-686

出版社

WILEY
DOI: 10.1002/mds.22870

关键词

essential tremor; SPECT

资金

  1. Parkinson's Disease Foundation

向作者/读者索取更多资源

To investigate over time changes in striatal dopamine transporter (DAT), we performed two sequential N-omega-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane single photon computed tomography (SPECT) scans in 20 subjects with essential tremor (ET), in 13 with Parkinson disease (PD) and in 23 healthy controls (HC, one scan only). We also performed an [Tc-99m]ethyl cysteinate dimer bicisate SPECT exam for regional brain network analysis in 9 ET, in a second group of 18 PD (9 with tremor, tPD and 9 akinetic-rigid dominant, arPD) and in 8 HC. PD subjects had a reduced DAT binding in comparison to ET and HC with an annual decline rate of 7.3% in the contralateral putamen. There were no mean uptake differences between ET and HC at baseline and no uptake loss over time in ET. A discriminant analysis grouped 30% (first scan) and 5% (second scan) of ET as PD and a partition analysis showed overlap between ET and PD for caudate nucleus uptake. Spatial covariance analysis revealed that the expression of the PD-related regional pattern separated both tPD and arPD from ET and HC. In conclusion, PD and ET do not share a common pattern of dopaminergic loss over time. However, mild impairment of dopamine transporter in the caudate nucleus may contribute to tremor onset in ET. (C) 2010 Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Onset and mortality of Parkinson's disease in relation to type II diabetes

Gianni Pezzoli, Emanuele Cereda, Paolo Amami, Santo Colosimo, Michela Barichella, Giorgio Sacilotto, Anna Zecchinelli, Michela Zini, Valentina Ferri, Carlotta Bolliri, Daniela Calandrella, Maria Grazia Bonelli, Viviana Cereda, Elisa Reali, Serena Caronni, Erica Cassani, Margherita Canesi, Francesca Del Sorbo, Paola Soliveri, Luigi Zecca, Catherine Klersy, Roberto Cilia, Ioannis U. Isaias

Summary: There is evidence suggesting a partial relationship between Parkinson's disease and diabetes. The occurrence of diabetes before the onset of Parkinson's disease delays its onset, while diabetes occurring after the onset of Parkinson's disease has no effect on survival. This study highlights the potential of antidiabetic drugs as a disease-modifying therapy for Parkinson's disease.

JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Modulation of Motor Vigor by Expectation of Reward Probability Trial-by-Trial Is Preserved in Healthy Ageing and Parkinson?s Disease Patients

Margherita Tecilla, Michael Grossbach, Giovanni Gentile, Peter Holland, Sebastian Sporn, Angelo Antonini, Maria Herrojo Ruiz

Summary: This study examines the impact of dynamically inferring action-reward contingencies on motor performance. The results show that stronger predictions about the tendency of the action-reward contingency lead to faster movement tempo, but have little effect on reaction time. Additionally, we found no significant differences in this effect between age and Parkinson's disease.

JOURNAL OF NEUROSCIENCE (2023)

Review Clinical Neurology

Functional brain networks in the evaluation of patients with neurodegenerative disorders

Matej Perovnik, Tomaz Rus, Katharina A. Schindlbeck, David Eidelberg

Summary: Network analytical tools are used to study brain diseases by analyzing imaging maps. Specific networks can be identified and validated, allowing for quantitative assessment of pathway changes over time and during treatment. Network abnormalities can be identified before symptoms and used to track disease progression and treatment efficacy. The development of analogous methods for functional MRI has expanded the application of network tools to diverse patient populations.

NATURE REVIEWS NEUROLOGY (2023)

Article Neurosciences

Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses

An Vo, Nha Nguyen, Koji Fujita, Katharina A. Schindlbeck, Andrea Rommal, Susan B. Bressman, Martin Niethammer, David Eidelberg

Summary: Primary dystonia is caused by abnormal functional relationships between basal ganglia and cerebellar motor circuits. Resting-state functional MRI (rs-fMRI) can provide unique information on the anatomy of abnormal brain circuits, and it is found that networks involving basal ganglia, cerebellum, thalamus, sensorimotor areas, and cortical association regions are elevated in hereditary and sporadic dystonia. The expression of these networks is correlated with dystonia motor ratings and can improve the accuracy of predictions for new treatments.

CEREBRAL CORTEX (2023)

Letter Clinical Neurology

Confusion of Evidence-Based Reviews and Guidelines

Guenther Deuschl, Angelo Antonini, Joao Costa, Katarzyna Smilowska, Daniela Berg, Jean-Christophe Corvol, Giovanni Fabbrini, Joaquim Ferreira, Tom Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evzen Ruzicka, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro

MOVEMENT DISORDERS (2023)

Review Clinical Neurology

Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Stefanie Jost, Marie-Ann Kaldenbach, Angelo Antonini, Pablo Martinez-Martin, Lars Timmermann, Per Odin, Regina Katzenschlager, Rupam Borgohain, Alfonso Fasano, Fabrizio Stocchi, Nobutaka Hattori, Prashanth Lingappa Kukkle, Mayela Rodriguez-Violante, Cristian Falup-Pecurariu, Sebastian Schade, Jan Niklas Petry-Schmelzer, Vinod Metta, Daniel Weintraub, Guenther J. Deuschl, Alberto J. Espay, Eng-King Tan, Roongroj Bhidayasiri, Victor S. C. Fung, Francisco Cardoso, Claudia Trenkwalder, Peter Jenner, K. S. Ray Chaudhuri, Haidar Dafsari

Summary: This study reviewed the investigations on drug therapy for Parkinson's disease since 2010 and proposed a new drug conversion formula. These conversion formulas can help us compare drug regimens across different clinical trials. The results are important for studying the pharmacological efficacy of Parkinson's disease treatments as well as other non-pharmacological interventions.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease

Aron Emmi, Michele Sandre, Francesco Paolo Russo, Giulia Tombesi, Federica Garri, Marta Campagnolo, Miryam Carecchio, Roberta Biundo, Gaya Spolverato, Veronica Macchi, Edoardo Savarino, Fabio Farinati, Piero Parchi, Andrea Porzionato, Luigi Bubacco, Raffaele De Caro, Gabor G. Kovacs, Angelo Antonini

Summary: This study revealed the presence of neuronal dysfunction and reactive gliosis in the duodenum of patients with Parkinson's disease, suggesting that the enteric nervous system is involved in the pathophysiology of the disease.

MOVEMENT DISORDERS (2023)

Correction Clinical Neurology

Functional brain networks in the evaluation of patients with neurodegenerative disorders (vol 19, pg 73, 2023)

Matej Perovnik, Tomaz Rus, Katharina A. A. Schindlbeck, David Eidelberg

NATURE REVIEWS NEUROLOGY (2023)

Article Neurosciences

NF-?B/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson?s disease patients

Vanessa Porrini, Andrea Pilotto, Marika Vezzoli, Annamaria Lanzillotta, Michele M. Gennari, Sonia Bonacina, Antonella Alberici, Rosanna Turrone, Arianna Bellucci, Angelo Antonini, Alessandro Padovani, Marina Pizzi

Summary: Although the key neuropathological hallmarks of Parkinson's disease (PD) are known, the underlying pathogenic mechanisms of the disease still need to be elucidated. This study focused on evaluating the levels and activity of c-Rel protein, which may be involved in PD pathophysiology. The findings suggest that PD is characterized by the loss of NF-κB/c-Rel activity, and the reduction of c-Rel DNA-binding could potentially serve as a novel biomarker for PD.

NEUROBIOLOGY OF DISEASE (2023)

Article Clinical Neurology

Toward objective monitoring of Parkinson's disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor®

Angelo Antonini, Heinz Reichmann, Giovanni Gentile, Michela Garon, Chiara Tedesco, Anika Frank, Bjoern Falkenburger, Spyridon Konitsiotis, Konstantinos Tsamis, Georgios Rigas, Nicholas Kostikis, Adamantios Ntanis, Constantinos Pattichis

Summary: This article describes the results of two clinical studies validating the performance of a new wearable monitoring device, PDMonitor, in detecting Parkinson's disease-related motor symptoms. The studies demonstrated high accuracy and correlation between the severity of symptoms and expert evaluations, confirming the effectiveness of the system as a continuous telemonitoring solution for facilitating treatment decisions in patients with Parkinson's disease.

FRONTIERS IN NEUROLOGY (2023)

Review Neurosciences

Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives

Valentina D'Onofrio, Nicoletta Manzo, Andrea Guerra, Andrea Landi, Valentina Baro, Sara Maeaettae, Luca Weis, Camillo Porcaro, Maurizio Corbetta, Angelo Antonini, Florinda Ferreri

Summary: Deep brain stimulation (DBS) is a promising treatment for neurological disorders, but its mechanisms of action are not fully understood. Transcranial magnetic stimulation (TMS) combined with DBS provides a unique approach to investigate the neurophysiology of the brain. Experimental studies have shown that DBS modulates cortical excitability and plasticity, which may contribute to its therapeutic effects. However, safety concerns limit the application of the TMS-DBS approach.

BRAIN SCIENCES (2023)

Article Neurosciences

Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei

Aron Emmi, Stefania Rizzo, Luisa Barzon, Michele Sandre, Elisa Carturan, Alessandro Sinigaglia, Silvia Riccetti, Mila Della Barbera, Rafael Boscolo-Berto, Patrizia Cocco, Veronica Macchi, Angelo Antonini, Monica De Gaspari, Cristina Basso, Raffaele De Caro, Andrea Porzionato

Summary: Neurological manifestations are common in COVID-19 patients, and this study found evidence of SARS-CoV-2 infection in the central nervous system. The researchers observed viral RNA and SARS-CoV-2-immunoreactive neurons in specific regions of the brain in COVID-19 patients. In addition, inflammation was observed in affected brainstem regions, indicating a role of brainstem inflammation in COVID-19. Further investigations are needed to understand the potential implications for neurodegenerative diseases like Parkinson's.

NPJ PARKINSONS DISEASE (2023)

Review Clinical Neurology

Current and novel infusion therapies for patients with Parkinson & apos;s disease

Angelo Antonini, Valentina D'Onofrio, Andrea Guerra

Summary: Advanced Parkinson's disease patients often experience poor mobility and functional decline despite medication adjustments. Drug delivery systems have been developed to bypass issues with oral levodopa absorption and have been proven effective in trials and real-world use. Future efforts should focus on early detection and global availability of these treatments.

JOURNAL OF NEURAL TRANSMISSION (2023)

Article Immunology

Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis

Lorenzo Lupi, Anna Bordin, Gabriele Sales, Davide Colaianni, Adriana Vitiello, Alberto Biscontin, Alberto Reale, Alfredo Garzino-Demo, Angelo Antonini, Giancarlo Ottaviano, Carla Mucignat, Cristina Parolin, Arianna Calistri, Cristiano De Pitta

Summary: COVID-19 is a respiratory syndrome that can cause various symptoms, including deficits in smell and taste. Transcriptome analysis of olfactory mucosa revealed altered gene expression levels in patients with persistent olfactory deficits, with associations with inflammatory response and zinc homeostasis.

FRONTIERS IN IMMUNOLOGY (2023)

Article Cell Biology

Brain Noradrenergic Innervation Supports the Development of Parkinson's Tremor: A Study in a Reserpinized Rat Model

Nicolo Gabriele Pozzi, Francesco Bolzoni, Gabriele Eliseo Mario Biella, Gianni Pezzoli, Chi Wang Ip, Jens Volkmann, Paolo Cavallari, Esther Asan, Ioannis Ugo Isaias

Summary: This study investigated the development of tremor in Parkinson's disease (PD) using a rat model with selective lesioning of LC-NA innervation. The results showed that LC-NA innervation plays a critical role in the development of PD tremor.
暂无数据